Clinical Trial Update: Vortioxetine in Patients With Depression Coexisting With General Anxiety Disorder (GAD) [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating vortioxetine in patients with major depressive disorder coexisting with generalized anxiety disorder has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Anxiety Disorder
• Major Depressive Disorder

Drugs mentioned

• Vortioxetine (vortioxetine)

Snippet

Sponsor: H. Lundbeck A/S | Conditions: MDD, Anxiety Disorders | Phase 4 | Status: COMPLETED